Lakewood-Amedex Biotherapeutics Inc.LABT
Price (close)
$1.82
Market cap
—
P/E
—
Revenue (FY)
—
Net income
—
Dividend yield
—
1-year total return
—
Net margin
—
Revenue growth
—
Debt / equity
—
What Lakewood-Amedex Biotherapeutics Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2024 | 2025 |
|---|
More on LABT.
- Lakewood-Amedex Biotherapeutics Inc. summary
- Lakewood-Amedex Biotherapeutics Inc. financial statements
- Lakewood-Amedex Biotherapeutics Inc. key metrics
- Lakewood-Amedex Biotherapeutics Inc. health scores and style box
- Lakewood-Amedex Biotherapeutics Inc. earnings
- Lakewood-Amedex Biotherapeutics Inc. dividends
- Lakewood-Amedex Biotherapeutics Inc. valuation
- Lakewood-Amedex Biotherapeutics Inc. ownership and insiders
- Lakewood-Amedex Biotherapeutics Inc. peers
Figures from Lakewood-Amedex Biotherapeutics Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.